share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  10/21 17:21

Moomoo AI 已提取核心訊息

180 Life Sciences Corp. has successfully completed a warrant inducement agreement with a holder of its existing warrants, resulting in the full exercise of warrants for cash and the issuance of new unregistered warrants. The agreement, initially reported on October 16, 2024, led to the holder exercising existing warrants to purchase 950,069 shares of common stock at $3.48 per share on October 16 and 17, 2024. This transaction provided the company with $3,306,240 before expenses. In return, the company issued new warrants to the holder to purchase double the number of shares acquired through the existing warrants at an exercise price of $1.50 per share, exercisable immediately and valid for five years. The issuance of these new warrants is exempt from registration under the Securities Act. The company corrected previous errors in reporting, adjusting the number of shares and the total funds raised from the exercise of the existing warrants. The corrected figures are 950,069 shares and $3,306,240, respectively.
180 Life Sciences Corp. has successfully completed a warrant inducement agreement with a holder of its existing warrants, resulting in the full exercise of warrants for cash and the issuance of new unregistered warrants. The agreement, initially reported on October 16, 2024, led to the holder exercising existing warrants to purchase 950,069 shares of common stock at $3.48 per share on October 16 and 17, 2024. This transaction provided the company with $3,306,240 before expenses. In return, the company issued new warrants to the holder to purchase double the number of shares acquired through the existing warrants at an exercise price of $1.50 per share, exercisable immediately and valid for five years. The issuance of these new warrants is exempt from registration under the Securities Act. The company corrected previous errors in reporting, adjusting the number of shares and the total funds raised from the exercise of the existing warrants. The corrected figures are 950,069 shares and $3,306,240, respectively.
180 Life Sciences Corp.已與持有其現有warrants的持有人成功完成了一項warrant誘因協議，導致warrants全部以現金行使併發行了新的未經註冊的warrants。該協議最初於2024年10月16日報告，導致持有人在2024年10月16日和17日行使現有warrants以$3.48每股的價格購買了950,069股普通股。該交易爲公司提供了$3,306,240，不包括費用。作爲回報，公司向持有人發行了新的warrants，以每股$1.50的價格購買現有warrants獲得的股份的兩倍數量，立即行使並在五年內有效。這些新warrants的發行符合《證券法》的註冊豁免。公司糾正了以前的報告錯誤，調整了通過行使現有warrants籌集的股份數和總支出金額。相應的更正數據爲950,069股和$3,306,240。
180 Life Sciences Corp.已與持有其現有warrants的持有人成功完成了一項warrant誘因協議，導致warrants全部以現金行使併發行了新的未經註冊的warrants。該協議最初於2024年10月16日報告，導致持有人在2024年10月16日和17日行使現有warrants以$3.48每股的價格購買了950,069股普通股。該交易爲公司提供了$3,306,240，不包括費用。作爲回報，公司向持有人發行了新的warrants，以每股$1.50的價格購買現有warrants獲得的股份的兩倍數量，立即行使並在五年內有效。這些新warrants的發行符合《證券法》的註冊豁免。公司糾正了以前的報告錯誤，調整了通過行使現有warrants籌集的股份數和總支出金額。相應的更正數據爲950,069股和$3,306,240。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間